Skip to main content
Top
Published in: Clinical Rheumatology 8/2019

01-08-2019 | Arthritis | Original Article

Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease

Authors: Rubén Queiro, Andrés Lorenzo, Patricia Tejón, Estefanía Pardo, Pablo Coto

Published in: Clinical Rheumatology | Issue 8/2019

Login to get access

Abstract

Background and aims

High blood pressure (HBP) is a common comorbidity in psoriatic disease. Some studies indicate a higher prevalence of HBP among arthritis patients, in relation to psoriasis alone, within the psoriatic spectrum. Our objective was to study the prevalence of HBP in both types of patients as well as to analyse the factors associated with it.

Methods

A cross-sectional observational study of 600 patients with psoriatic disease attended in a multidisciplinary clinic of a reference centre. We first analysed the frequency of this comorbidity and then the factors associated with it using conditional logistic regression. The significant factors in this first model were introduced in a multivariate model using a backward step approach.

Results

A total of 144 patients were hypertensive (24%). Of patients with arthritis, 86/290 (29.7%) had HBP, compared with 58/310 (18.7%) with psoriasis (OR 1.7 95%, CI 1.25–2.50, p = 0.003). Hypertension was independently associated with higher age at onset of psoriasis (OR 1.04, 95%CI 1.03–1.06, p < 0.001) and a higher body mass index (OR 1.13, 95%CI, 1.06–1.22, p < 0.001).

Conclusions

HBP is more prevalent in patients with arthritis within the spectrum of psoriatic disease. Patients with a higher body mass index and those with later-onset psoriasis are more prone to this comorbidity.

Key Points

• The factors of psoriatic disease associated with HBP are little known.
• HBP is more prevalent in patients with arthritis within the spectrum of psoriatic disease.
• In patients with psoriatic disease, for each point of increase in the body mass index, the risk of HBP increases by 13%.
• For each year of onset of psoriasis above 40 years, the risk of HBP increases by 4%.
Literature
1.
go back to reference Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin N Am 41:545–568CrossRef Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin N Am 41:545–568CrossRef
2.
go back to reference Scarpa R, Caso F, Costa L, Peluso R, Del Puente A, Olivieri I (2017) Psoriatic disease 10 years later. J Rheumatol 44:1298–1301CrossRefPubMed Scarpa R, Caso F, Costa L, Peluso R, Del Puente A, Olivieri I (2017) Psoriatic disease 10 years later. J Rheumatol 44:1298–1301CrossRefPubMed
3.
go back to reference Yim KM, Armstrong AW (2017) Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int 37:97–105CrossRefPubMed Yim KM, Armstrong AW (2017) Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int 37:97–105CrossRefPubMed
4.
go back to reference Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E (2013) Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 169:783–793CrossRefPubMed Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E (2013) Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 169:783–793CrossRefPubMed
5.
go back to reference Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63:1729–1735CrossRef Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63:1729–1735CrossRef
6.
go back to reference González-Juanatey C, Llorca J, Amigo-Díaz E, Dierssen T, Martín J, González-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:1074–1080CrossRefPubMed González-Juanatey C, Llorca J, Amigo-Díaz E, Dierssen T, Martín J, González-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:1074–1080CrossRefPubMed
7.
go back to reference Eder L, Chandran V, Gladman DD (2014) The Framingham risk score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis 73:1990–1996CrossRefPubMed Eder L, Chandran V, Gladman DD (2014) The Framingham risk score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis 73:1990–1996CrossRefPubMed
8.
go back to reference Armstrong AW, Harskamp CT, Armstrong EJ (2013) The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens 31:433–443CrossRefPubMed Armstrong AW, Harskamp CT, Armstrong EJ (2013) The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens 31:433–443CrossRefPubMed
9.
go back to reference Takeshita J, Wang S, Shin DB, Mehta NN, Kimmel SE, Margolis DJ, Troxel AB, Gelfand JM (2015) Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol 151:161–169CrossRefPubMedPubMedCentral Takeshita J, Wang S, Shin DB, Mehta NN, Kimmel SE, Margolis DJ, Troxel AB, Gelfand JM (2015) Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol 151:161–169CrossRefPubMedPubMedCentral
10.
go back to reference Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed
11.
go back to reference Queiro R, Coto P (2017) Multidisciplinary care for psoriatic disease: where we are and where we need to go. Rheumatology (Oxford) 56:1829–1831 Queiro R, Coto P (2017) Multidisciplinary care for psoriatic disease: where we are and where we need to go. Rheumatology (Oxford) 56:1829–1831
12.
go back to reference Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783CrossRefPubMed Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783CrossRefPubMed
14.
go back to reference Queiro R, Tejón P, Alonso S, Coto P (2014) Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology (Oxford) 53:1178–1185CrossRef Queiro R, Tejón P, Alonso S, Coto P (2014) Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology (Oxford) 53:1178–1185CrossRef
15.
go back to reference Alonso S, Tejón P, Sarasqueta C, Coto P, Alperi M, Queiro R (2016) Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis. Joint Bone Spine 83:533–537CrossRefPubMed Alonso S, Tejón P, Sarasqueta C, Coto P, Alperi M, Queiro R (2016) Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis. Joint Bone Spine 83:533–537CrossRefPubMed
16.
go back to reference Bonifati C, Mussi A, Carducci M, Pittarello A, D'Auria L, Venuti A et al (1998) Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 78:22–26CrossRefPubMed Bonifati C, Mussi A, Carducci M, Pittarello A, D'Auria L, Venuti A et al (1998) Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 78:22–26CrossRefPubMed
17.
go back to reference Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S et al (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449–2460CrossRefPubMedPubMedCentral Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S et al (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449–2460CrossRefPubMedPubMedCentral
18.
go back to reference Suárez-Fariñas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG (2012) Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132:2552–2564CrossRefPubMedPubMedCentral Suárez-Fariñas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG (2012) Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132:2552–2564CrossRefPubMedPubMedCentral
19.
go back to reference Puig L (2018) Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci 19:58CrossRef Puig L (2018) Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci 19:58CrossRef
20.
go back to reference Lin YC, Dalal D, Churton S, Brennan DM, Korman NJ, Kim ES et al (2014) Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res 66:97–103CrossRef Lin YC, Dalal D, Churton S, Brennan DM, Korman NJ, Kim ES et al (2014) Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res 66:97–103CrossRef
Metadata
Title
Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease
Authors
Rubén Queiro
Andrés Lorenzo
Patricia Tejón
Estefanía Pardo
Pablo Coto
Publication date
01-08-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04519-z

Other articles of this Issue 8/2019

Clinical Rheumatology 8/2019 Go to the issue